Clinical Trial Update: Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intranasal oxytocin to improve sexual well-being in patients with arginine vasopressin deficiency and healthy controls. Cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arginine Vasopressin Deficiency
• Central Diabetes Insipidus

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Arginine Vasopressin Deficiency, Central Diabetes Insipidus | Phase 2 | Status: RECRUITING